Clinical TrialsSearch results
Number of results: 200
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- A prospective, multicentre, observational trial for hemodynamic reaction following initial fluid resuscitation in patients with hemorrhagic shock due to blunt trauma
- Trauma patients with hemorrhagic shock
- The General Planning Committee of Japanese Association for the Surgery of Trauma
- 2008-03-07
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan
- Cardiopulmonary arrest on arrival(CPAOA)
- Teikyo University School of Medicine, Teikyo University Hospital
- 2008-10-01
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Recruiting
- Research on the effect of UHA Gummy Supplement Iron intake on anemia symptoms (UHA-IRON-GS)
- anaemia
- Takemoto Yuji
- 2023-04-19
Completed
- PROUD48
- Dyslipidemic patients
- Takeda Yasutaka
- 2020-04-28
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01